Jaume Capdevila, Jorge Hernando, Javier Molina-Cerillo, Maria Plana Serrahima, Miren Taberna Sanz, Beatriz Castelo, Cristina Álvarez-Escolá, Alberto Carmona-Bayonas, Inmaculada Ballester Navarro, Lara Iglesias, Mateo Bover, Alejandro Garcia-Alvarez, Javier Lavernia, Ricardo Yayá Tur, Sofia Ruiz, Neus Baste, Isabel Lorenzo-Lorenzo, Alfredo Sanchez-Hernandez, Enrique Sanz-Garcia, Gloria Marquina, Paolo Nuciforo, Belén Elguero, Enrique Grande, Teresa Alonso-Gordoa. "Durvalumab plus tremelimumab for the treatment of patients with progressive, refractory advanced thyroid carcinoma: the phase II GETNE-DUTHY trial." Nature Communications, 2026. doi:10.1038/s41467-026-71155-y